The Polish treasury will sell its majority stake in chemical maker Police to state-owned rival Tarnow, it said on Thursday, as the government consolidates the sector ahead of full privatization.

Tarnow offered 11.5 zlotys per share for the treasury's 59.4% in Police.

It is also in the process of purchasing an additional 40% stake in its former rival ZAK in which it is now a majority shareholder. The treasury holds 41% in ZAK.
Tarnow plans a rights issue worth 1.1 billion zlotys to finance that deal, among others.

The treasury also said on Thursday it was willing to sell all its rights to the new shares to a third party, which would lower Warsaw's stake in Tarnow.
 ING Securities would lead book-building for the transaction, the treasury added.

"Such a consolidation process is an overture to the full privatization of this part of the chemical sector," Treasury Minister Aleksander Grad said in the statement.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.